CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

QQQ $ 464.41 $ 1.62 (0.35 %)

DIA $ 387.81 $ -0.68 (-0.18 %)

SPY $ 534.71 $ 1.46 (0.27 %)

TLT $ 90.88 $ -0.15 (-0.17 %)

GLD $ 213.32 $ 0.24 (0.11 %)

Previous Close

$ 214.79

Open

$ 212.85

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 211.85 - $ 214.03

52 Week Range

$ 161.65 - $ 275.00

Volume

464,634

Average Volume

Market Cap

11.14B

Beta (5Y Monthly)

$ 1.34

PE Ratio (TTM)

$ 25.05

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-30-2024	10-Q
2	02-14-2024	12-30-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-09-2023	07-01-2023	10-Q
5	05-11-2023	04-01-2023	10-Q
6	02-22-2023	12-31-2022	10-K
7	11-02-2022	09-24-2022	10-Q
8	08-03-2022	06-25-2022	10-Q
9	05-04-2022	03-26-2022	10-Q
10	02-16-2022	12-25-2021	10-K
11	11-03-2021	09-25-2021	10-Q
12	08-04-2021	06-26-2021	10-Q
13	05-04-2021	03-27-2021	10-Q
14	02-17-2021	12-26-2020	10-K
15	11-09-2020	09-26-2020	10-Q
16	10-29-2020	09-26-2020	10-Q
17	08-05-2020	06-27-2020	10-Q
18	05-07-2020	03-28-2020	10-Q
19	02-11-2020	12-28-2019	10-K
20	11-06-2019	09-28-2019	10-Q
21	07-31-2019	06-29-2019	10-Q
22	05-07-2019	03-30-2019	10-Q
23	02-13-2019	12-29-2018	10-K
24	11-07-2018	09-29-2018	10-Q
25	08-08-2018	06-30-2018	10-Q
26	05-10-2018	03-31-2018	10-Q
27	02-13-2018	12-30-2017	10-K
28	11-09-2017	09-30-2017	10-Q
29	08-09-2017	07-01-2017	10-Q
30	05-10-2017	04-01-2017	10-Q
31	02-14-2017	12-31-2016	10-K
32	11-02-2016	09-24-2016	10-Q
33	08-03-2016	06-25-2016	10-Q
34	05-04-2016	03-26-2016	10-Q
35	02-12-2016	12-26-2015	10-K
36	11-04-2015	09-26-2015	10-Q
37	07-30-2015	06-27-2015	10-Q
38	04-30-2015	03-28-2015	10-Q
39	02-17-2015	12-27-2014	10-K
40	10-30-2014	09-27-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Mizuho Initiates Coverage On Charles River...
06/07/2024 10:42:02

Mizuho analyst Ann Hynes initiates coverage on Charles River (NYSE:CRL) with a Neutral rating and announces Price Target of ...

The Analyst Verdict: Charles River In The ...
06/06/2024 13:00:46

Goldman Sachs Initiates Coverage On Charle...
06/06/2024 12:57:36

Goldman Sachs analyst Matthew Sykes initiates coverage on Charles River (NYSE:CRL) with a Buy rating and announces Price Tar...

Charles River Laboratories Announces Openi...
06/06/2024 12:14:25

Charles River Introduces Its Vector Tech T...
05/30/2024 12:02:56

Fast Track and Modular frameworks facilitate product development continuity via seamless process transfer to the Company's ...

TD Cowen Maintains Hold on Charles River, ...
05/13/2024 16:18:45

TD Cowen analyst Charles Rhyee maintains Charles River (NYSE:CRL) with a Hold and lowers the price target from $260 to $228.

The Analyst Landscape: 7 Takes On Charles ...
05/10/2024 12:00:43

Baird Maintains Outperform on Charles Rive...
05/10/2024 11:21:34

Baird analyst Eric Coldwell maintains Charles River (NYSE:CRL) with a Outperform and lowers the price target from $282 to $270.

Charles River Laboratories Reaffirms Outlo...
05/09/2024 11:11:24

Despite modest adjustments to the quarterly gating in 2024, the Company's outlook for the year remains essentially unchang...

Charles River Q1 2024 Adj EPS $2.27 Beats ...
05/09/2024 11:02:38

Charles River (NYSE:CRL) reported quarterly earnings of $2.27 per share which beat the analyst consensus estimate of $2.07 by 9...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
05/07/2024 17:35:23

Charles River Launches Viral Vector Refere...
05/02/2024 12:14:25

Supporting scale-up for early-phase AAV- and LVV-based gene and gene-modified cell therapy researchers and developersCharles Ri...

FibroBiologics, Charles River Laboratories...
04/25/2024 12:02:58

This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of Fib...

Charles River Laboratories Launches Altern...
04/16/2024 12:04:39

Charles River To Perform Plasmid Productio...
04/04/2024 12:09:49

GMP grade plasmid DNA to serve as a direct therapeutic targeting various indicationsCharles River Laboratories International, I...

Charles River Announces Extension Of Gene ...
03/21/2024 12:04:57

Evaluating Charles River: Insights From 7 ...
03/18/2024 18:01:03

Argus Research Maintains Buy on Charles Ri...
03/18/2024 14:12:20

Argus Research analyst David Toung maintains Charles River (NYSE:CRL) with a Buy and raises the price target from $200 to $290.

Charles River And Navega Therapeutics Anno...
03/14/2024 12:17:22

Next-generation AAV gene therapy to target debilitating pain disorders Charles River Laboratories International, Inc. (NYSE:CR...

Durect Corporation Has Entered Into A Co-m...
03/04/2024 12:02:35

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)

07/01/2024 Equinix, Inc. (EQIX)

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)

CRLCHARLES RIVER LABORATORIES ...

NYSE criver.com

$ 212.83 $ -1.96 (-0.91 %)

Monday, 10-Jun-2024 11:57:47 EDT